BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8245232)

  • 1. Equine pituitary adenoma: a functional and morphological study.
    Boujon CE; Bestetti GE; Meier HP; Straub R; Junker U; Rossi GL
    J Comp Pathol; 1993 Aug; 109(2):163-78. PubMed ID: 8245232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
    Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
    Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial cell adenoma of the hypophysis with Cushing-like symptomatology in the horse].
    Pauli BU; Rossi Straub R
    Vet Pathol; 1974; 11(5):417-29. PubMed ID: 4376879
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses.
    Heinrichs M; Baumgärtner W; Capen CC
    Vet Pathol; 1990 Nov; 27(6):419-25. PubMed ID: 2177580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoperoxidase study of a human pituitary adenoma associated with Cushing's syndrome.
    Wowra B; Peiffer J
    Pathol Res Pract; 1984 Mar; 178(4):349-54. PubMed ID: 6328462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathology and pathogenesis of pituitary corticotroph adenoma].
    Trouillas J
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion pattern of pro-opiomelanocortin-derived peptides by a pituitary adenoma from a patient with Cushing's disease.
    Shibasaki T; Masui H; Sato G; Ling N; Guillemin R
    J Clin Endocrinol Metab; 1981 Feb; 52(2):350-3. PubMed ID: 6257745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative immunohistochemical study of stellate cells in normal canine and equine adenohypophyses and in pituitary tumours.
    Méndez A; Martín de las Mulas J; Bautista MJ; Chacón F; Millán Y; Fondevila D; Pumarola M
    J Comp Pathol; 1998 Jan; 118(1):29-40. PubMed ID: 9500236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent production of adrenocorticotropin and prolactin from two distinct cell lines in a single pituitary adenoma: a detailed immunohistochemical analysis.
    Sherry SH; Guay AT; Lee AK; Hedley Whyte ET; Federman M; Freidberg SR; Woolf PD
    J Clin Endocrinol Metab; 1982 Nov; 55(5):947-55. PubMed ID: 6288757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical study of the hypophysis in 25 dogs with pituitary-dependent hyperadrenocorticism.
    Peterson ME; Krieger DT; Drucker WD; Halmi NS
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):15-24. PubMed ID: 6289590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of the pituitary.
    Doniach I
    Clin Endocrinol Metab; 1985 Nov; 14(4):765-89. PubMed ID: 3002676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro secretion of pro-opiomelanocortin (POMC) derived peptides in human ACTH-producing pituitary adenomas: evaluation of hormone ratios in different functional states.
    Westphal M; Lüdecke DK
    Mol Cell Endocrinol; 1984 Sep; 37(2):145-51. PubMed ID: 6092171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current topics in neuropathology. Cushing's disease.
    McNicol AM
    Neuropathol Appl Neurobiol; 1985; 11(6):485-94. PubMed ID: 2869423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
    Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
    Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of ACTH-producing pituitary lesions.
    Lloyd RV; Chandler WF; McKeever PE; Schteingart DE
    Am J Surg Pathol; 1986 Sep; 10(9):618-26. PubMed ID: 2428263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational processing of pro-opiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development. II. beta-Lipotropin (beta-LPH)-related peptides.
    Hatfield JM; Allen RG; Stack J; Ronnekleiv O
    Dev Biol; 1988 Mar; 126(1):164-72. PubMed ID: 2963776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional morphology of spontaneous hyperplastic and neoplastic lesions in the canine pituitary gland.
    El Etreby MF; Müller-Peddinghaus R; Bhargava AS; Trautwein G
    Vet Pathol; 1980 Mar; 17(2):109-22. PubMed ID: 6244687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease.
    Orth DN; Nicholson WE
    Endocrinology; 1982 Aug; 111(2):559-63. PubMed ID: 6284484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of equine thyroid follicular carcinoma accompanied with adenohypophysial adenoma.
    Chiba S; Okada K; Numakunai S; Ohshima K
    Nihon Juigaku Zasshi; 1987 Jun; 49(3):551-4. PubMed ID: 3613355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.